Back
Neurocrine Biosciences Vs. Bruker Industry Stock Comparison
Buy
57
NBIX
Neurocrine Biosciences
Last Price:
123.96
Seasonality Move:
16.93%
Sell
38
BRKR
Bruker
Last Price:
60.51
Seasonality Move:
2.09%
Buy
57
Neurocrine Biosciences (NBIX)
is a Buy
Is Neurocrine Biosciences a Buy, Sell or Hold?
- The current Neurocrine Biosciences [NBIX] share price is $125.30. The Score for NBIX is 57, which is 14% above its historic median score of 50, and infers lower risk than normal.
- NBIX is currently trading in the 50-60% percentile range relative to its historical Stock Score levels.
- This Score is currently showing a higher than normal reading, suggesting risk levels may be somewhat lower than normal.
Sell
38
Bruker (BRKR)
is a Sell
Is Bruker a Buy, Sell or Hold?
- The current Bruker [BRKR] share price is $58.94. The Score for BRKR is 38, which is 24% below its historic median score of 50, and infers higher risk than normal.
- BRKR is currently trading in the 30-40% percentile range relative to its historical Stock Score levels.
- This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
NBIX Stock Price Chart
What is Neurocrine Biosciences's stock price today?
-
The Neurocrine Biosciences share price today is $125.30
Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and NBIX is experiencing slight buying pressure.
NBIX Technical Analysis
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | 0.91 | Buy |
| Relative Strength Index (14 RSI): | 62.95 | Buy |
| Chaikin Money Flow: | 495738 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (113.03 - 120.55) | Buy |
| Bollinger Bands (100): | (117.75 - 145.33) | Sell |
BRKR Technical Analysis
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | -1.6 | Sell |
| Relative Strength Index (14 RSI): | 42.58 | Sell |
| Chaikin Money Flow: | -1644576 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (58.6 - 64.84) | Sell |
| Bollinger Bands (100): | (61.12 - 66.82) | Sell |
NBIX Moving Averages
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 120.81 | Buy |
| 20-day SMA: | 117.81 | Buy |
| 50-day SMA: | 119.15 | Buy |
| 200-day SMA: | 134.51 | Sell |
| 8-day EMA: | 121.17 | Buy |
| 20-day EMA: | 119.15 | Buy |
| 50-day EMA: | 121.98 | Buy |
| 200-day EMA: | 128.49 | Sell |
BRKR Moving Averages
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 58.82 | Buy |
| 20-day SMA: | 60.6 | Sell |
| 50-day SMA: | 63.99 | Sell |
| 200-day SMA: | 71.99 | Sell |
| 8-day EMA: | 59.36 | Sell |
| 20-day EMA: | 60.67 | Sell |
| 50-day EMA: | 62.87 | Sell |
| 200-day EMA: | 67.81 | Sell |
Neurocrine Biosciences Earnings Growth & NBIX Earnings Dates
- Analysts estimate an earnings increase this quarter of $0.30 per share, a decrease next quarter of $0.00 per share, an increase this year of $2.39 per share, and an increase next year of $1.11 per share.
Bruker Earnings Growth & BRKR Earnings Dates
- Analysts estimate an earnings decrease this quarter of $0.20 per share, a decrease next quarter of $0.00 per share, a decrease this year of $0.16 per share, and an increase next year of $0.37 per share.
Neurocrine Biosciences Technical Analysis
| Oct 24 | Oct 25 | Oct 28 | Oct 29 | Oct 30 | Oct 31 | Nov 1 | Nov 4 | Nov 5 | Nov 6 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Oct | Nov | |||||||||
| 24 | 25 | 28 | 29 | 30 | 31 | 01 | 04 | 05 | 06 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||
Bruker Technical Analysis
| Oct 24 | Oct 25 | Oct 28 | Oct 29 | Oct 30 | Oct 31 | Nov 1 | Nov 4 | Nov 5 | Nov 6 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Oct | Nov | |||||||||
| 24 | 25 | 28 | 29 | 30 | 31 | 01 | 04 | 05 | 06 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||